Organization Profile

You just read:

Health Canada Has Now Authorized ADYNOVATE® [Antihemophilic Factor (Recombinant), PEGylated] in Pediatrics for Treatment of Children Under 12 with Hemophilia A[1]

News provided by

Shire Pharma Canada ULC

Nov 26, 2018, 07:00 ET